Overuse and underuse in general medical expenditure is a pressing dilemma identified by medical professionals globally, and in need of wide-ranging solutions. In fact the largest growing cost to governments and individuals in Australia over the past 20 years has been health expenditure.
In 2013-2014 subsidised pharmaceutical expenditure exceeded $10.1 billion, second only to medical services. In the same period spending on private prescriptions and over-the-counter (OTC) medicines was $9.7 billion; 93% being paid by individuals (Australian Institute of Health and Welfare, 2014). The market for all prescriptions and OTC medicines being worth more than $19.76 billion, which equated to 1.4% of Australian Gross Domestic Product (GDP) for 2014.
The frequency of this problem across different markets, countries and health sectors shows there is systematic failure in health care delivery (Brownlee et al. 2017; Saini et al. 2017). And the implications of inappropriate care have significant flow-on effects to global public health policy, not to mention the individual patients and health sector workers involved.
In this study we develop a field experiment with simulated patients to assess pharmacy over-the-counter compliance in diagnosis and treatment using therapeutic guidelines as a clinical benchmark
Funding / Grants
- ARC Linkage Grant DP110103653 (2015 - 2018)
Other Team Members
- Ms Harriet Smith
- Professor Lisa M. Nissen
- Professor Greg Kyle
- Dr Esther T. Lau
- Smith, Harriet, Whyte, Stephen, Chan, Ho Fai, Kyle, Gregory, Lau, Esther T.L., Nissen, Lisa M., Torgler, Benno, & Dulleck, Uwe (2019) Pharmacist compliance with therapeutic guidelines on diagnosis and treatment provision. JAMA Network Open, 2(7), Article e197168.
View on ePrints